Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

55.05
+0.04000.07%
Post-market: 55.050.00000.00%19:50 EDT
Volume:4.48M
Turnover:246.43M
Market Cap:7.71B
PE:37.32
High:56.57
Open:55.86
Low:54.02
Close:55.01
52wk High:76.76
52wk Low:9.57
Shares:140.01M
Float Shares:120.00M
Volume Ratio:1.61
T/O Rate:3.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.48
EPS(LYR):-0.0122
ROE:75.50%
ROA:14.35%
PB:13.56
PE(LYR):-4,514.89

Loading ...

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of Aro-Dimer-Pa – the First Dual Functional Rnai Therapeutic for the Treatment of Mixed Hyperlipidemia

THOMSON REUTERS
·
Jan 27

Arrowhead Pharmaceuticals Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Jan 27

Arrowhead Pharmaceuticals (ARWR) Is Up 5.0% After China Approves Redemplo Commercialisation With Sanofi

Simply Wall St.
·
Jan 25

B. Riley Raises Price Target on Arrowhead Pharmaceuticals to $101 From $61, Keeps Buy Rating

MT Newswires Live
·
Jan 22

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arrowhead Pharmaceuticals (ARWR) and Alector (ALEC)

TIPRANKS
·
Jan 21

Arrowhead Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 21

Arrowhead Pharmaceuticals : H.c. Wainwright Raises Target Price to $100 From $85

THOMSON REUTERS
·
Jan 21

Arrowhead price target raised to $100 from $85 at H.C. Wainwright

TIPRANKS
·
Jan 21

U.S. RESEARCH ROUNDUP-IBM, KLA, WEX

Reuters
·
Jan 21

Arrowhead Pharmaceuticals Inc. to Webcast Fiscal 2026 First Quarter Results

Reuters
·
Jan 21

Arrowhead Pharmaceuticals Price Target Raised to $110.00/Share From $100.00 by Piper Sandler

Dow Jones
·
Jan 13

U.S. RESEARCH ROUNDUP-Cencora, Kennametal, Regeneron Pharmaceuticals

Reuters
·
Jan 13

Arrowhead Pharmaceuticals Issues Zero-Coupon 2032 Convertible Notes

TIPRANKS
·
Jan 13

Arrowhead Pharmaceuticals - Issues $700 Mln of 0.00% Convertible Notes Due 2032 - SEC Filing

THOMSON REUTERS
·
Jan 13

Arrowhead Pharmaceuticals Issues $700 Million Convertible Senior Notes Due 2032

Reuters
·
Jan 13

Innovative Drug Sector's Booster Shot! Piper Sandler Bets on "Gene Silencing" Leader Arrowhead (ARWR.US), Predicts Stock to Soar 55%

Stock News
·
Jan 12

How Investors May Respond To Arrowhead Pharmaceuticals (ARWR) China Approval Expanding REDEMPLO RNAi Metabolic Footprint

Simply Wall St.
·
Jan 11

Arrowhead Pharmaceuticals Launches Major Equity and Notes Offerings

TIPRANKS
·
Jan 09

Arrowhead Pharmaceuticals Prices Offerings of Notes, Common Stock, Pre-Funded Warrants

MT Newswires Live
·
Jan 08

BRIEF-Arrowhead Pharmaceuticals Offers 3,100,776 Shares At $64.50 Per Share

Reuters
·
Jan 08